The landscape analysis based on TCGA shows that IGF2BP1 level is increased in clear cell renal cell carcinoma (ccRCC) and high expression of IGF2BP1 is closely correlated with the lower survival of ccRCC patients. The gene discussed is IGF2BP1; the disease is nonpapillary renal cell carcinoma.